Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0092 | 0.3276 | 0.1976 |
Plasmodium vivax | unspecified product | 0.0177 | 0.9044 | 0.8578 |
Brugia malayi | DNA gyrase/topoisomerase IV, A subunit family protein | 0.0168 | 0.8443 | 0.8141 |
Trichomonas vaginalis | DNA topoisomerase II, putative | 0.0168 | 0.8443 | 0.8958 |
Plasmodium falciparum | thioredoxin reductase | 0.0191 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0191 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0173 | 0.8756 | 0.9501 |
Toxoplasma gondii | hypothetical protein | 0.0177 | 0.9044 | 0.8578 |
Schistosoma mansoni | DNA topoisomerase II | 0.0168 | 0.8443 | 0.7684 |
Echinococcus multilocularis | DNA topoisomerase 2 alpha | 0.0168 | 0.8443 | 0.7684 |
Toxoplasma gondii | thioredoxin reductase | 0.0191 | 1 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0173 | 0.8756 | 1 |
Mycobacterium tuberculosis | DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) | 0.0098 | 0.3687 | 0.0612 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0173 | 0.8756 | 0.815 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0173 | 0.8756 | 0.9501 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0191 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0173 | 0.8756 | 0.9501 |
Leishmania major | mitochondrial DNA topoisomerase II | 0.0189 | 0.9839 | 0.976 |
Trypanosoma brucei | DNA topoisomerase II beta, putative | 0.0159 | 0.7827 | 0.6768 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0092 | 0.3276 | 0.3741 |
Loa Loa (eye worm) | TOPoisomerase family member | 0.0168 | 0.8443 | 0.8129 |
Treponema pallidum | DNA gyrase, subunit B (gyrB) | 0.0098 | 0.3687 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.4755 | 0.3699 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0191 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0173 | 0.8756 | 0.815 |
Plasmodium falciparum | esterase, putative | 0.0177 | 0.9044 | 0.8578 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0173 | 0.8756 | 0.9501 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0173 | 0.8756 | 0.5217 |
Brugia malayi | Probable DNA topoisomerase II | 0.0168 | 0.8443 | 0.8141 |
Leishmania major | DNA topoisomerase ii | 0.0159 | 0.7827 | 0.6768 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0173 | 0.8756 | 0.9501 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0173 | 0.8756 | 0.5217 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0177 | 0.9044 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0114 | 0.4755 | 0.3699 |
Plasmodium falciparum | esterase, putative | 0.0173 | 0.8756 | 0.815 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0173 | 0.8756 | 0.9501 |
Plasmodium vivax | DNA gyrase subunit B, putative | 0.0098 | 0.3687 | 0.0612 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0189 | 0.9839 | 0.976 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0177 | 0.9044 | 1 |
Echinococcus granulosus | DNA topoisomerase 2 alpha | 0.0168 | 0.8443 | 0.7684 |
Plasmodium falciparum | lysophospholipase, putative | 0.0173 | 0.8756 | 0.815 |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0159 | 0.7827 | 0.6768 |
Trypanosoma cruzi | mitochondrial DNA topoisomerase II, putative | 0.0189 | 0.9839 | 0.976 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0114 | 0.4744 | 0.5 |
Onchocerca volvulus | Putative DNA topoisomerase 2, mitochondrial | 0.0114 | 0.4744 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0191 | 1 | 1 |
Brugia malayi | DNA topoisomerase II, alpha isozyme | 0.0168 | 0.8443 | 0.8141 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0098 | 0.3687 | 0.0612 |
Giardia lamblia | DNA topoisomerase II | 0.016 | 0.7848 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0173 | 0.8756 | 0.9501 |
Mycobacterium ulcerans | lysophospholipase | 0.0173 | 0.8756 | 1 |
Plasmodium falciparum | DNA gyrase subunit B | 0.0098 | 0.3687 | 0.0612 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0191 | 1 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0191 | 1 | 1 |
Trypanosoma brucei | DNA topoisomerase II alpha, putative | 0.0159 | 0.7827 | 0.6768 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0092 | 0.3276 | 0.7054 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0191 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0177 | 0.9044 | 0.8578 |
Toxoplasma gondii | DNA topoisomerase 2, putative | 0.0168 | 0.8443 | 0.7684 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0173 | 0.8756 | 0.815 |
Onchocerca volvulus | DNA topoisomerase 2 homolog | 0.0114 | 0.4744 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0191 | 1 | 1 |
Leishmania major | monoglyceride lipase, putative | 0.0173 | 0.8756 | 0.815 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0173 | 0.8756 | 0.815 |
Plasmodium falciparum | lysophospholipase, putative | 0.0173 | 0.8756 | 0.815 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0173 | 0.8756 | 0.815 |
Plasmodium falciparum | esterase, putative | 0.0177 | 0.9044 | 0.8578 |
Trypanosoma cruzi | DNA topoisomerase II, putative | 0.0159 | 0.7827 | 0.6768 |
Mycobacterium ulcerans | hypothetical protein | 0.0173 | 0.8756 | 1 |
Mycobacterium ulcerans | DNA gyrase subunit B | 0.0098 | 0.3687 | 0.0751 |
Trypanosoma brucei | trypanothione reductase | 0.0191 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | DNA gyrase, topoisomerase II, B subunit, GyrB | 0.0098 | 0.3687 | 1 |
Plasmodium vivax | lysophospholipase, putative | 0.0177 | 0.9044 | 0.8578 |
Plasmodium vivax | PST-A protein | 0.0173 | 0.8756 | 0.815 |
Plasmodium falciparum | glutathione reductase | 0.0191 | 1 | 1 |
Plasmodium vivax | DNA topoisomerase II, putative | 0.0168 | 0.8443 | 0.7684 |
Chlamydia trachomatis | DNA gyrase subunit B | 0.0098 | 0.3687 | 1 |
Leishmania major | trypanothione reductase | 0.0191 | 1 | 1 |
Plasmodium falciparum | DNA topoisomerase 2 | 0.0168 | 0.8443 | 0.7684 |
Trypanosoma brucei | DNA topoisomerase ii | 0.0189 | 0.9839 | 0.976 |
Loa Loa (eye worm) | glutathione reductase | 0.0191 | 1 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0173 | 0.8756 | 0.9501 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.